| Immunotherapeutic molecules and uses M Cobbold, D Millar US Patent 9,822,180, 2017 | 65 | 2017 |
| Antibody-mediated delivery of viral epitopes to tumors harnesses CMV-specific T cells for cancer therapy DG Millar, RR Ramjiawan, K Kawaguchi, N Gupta, J Chen, S Zhang, ... Nature biotechnology 38 (4), 420-425, 2020 | 59 | 2020 |
| Re-directed immunotherapy M Cobbold, D Millar US Patent 9,402,916, 2016 | 46 | 2016 |
| IL 7R versus CCR7 and CD45 as markers of virus specific CD8+ T cell differentiation: Contrasting pictures in blood and tonsillar lymphoid tissue. AB Sauce, D., Larsen, M., Leese, AM., Millar, D., Khan, N., Hislop, AD ... Journal of Infectious Diseases 195 (2), 268-278, 2007 | 32 | 2007 |
| Immunotherapeutic molecules and uses M Cobbold, D Millar US Patent 9,650,445, 2017 | 31 | 2017 |
| Accelerated loss of TCR repertoire diversity in common variable immunodeficiency GK Wong, D Millar, S Penny, JM Heather, P Mistry, N Buettner, J Bryon, ... The Journal of Immunology 197 (5), 1642-1649, 2016 | 20 | 2016 |
| Single-cell imaging of T cell immunotherapy responses in vivo C Yan, Q Yang, S Zhang, DG Millar, EJ Alpert, D Do, A Veloso, ... Journal of Experimental Medicine 218 (10), e20210314, 2021 | 17 | 2021 |
| Stitchr: stitching coding TCR nucleotide sequences from V/J/CDR3 information JM Heather, MJ Spindler, MH Alonso, YI Shui, DG Millar, DS Johnson, ... Nucleic acids research 50 (12), e68-e68, 2022 | 13 | 2022 |
| 31st annual meeting and associated programs of the society for immunotherapy of cancer (Sitc 2016): Part two: National harbor, md, USA. 9-13 November 2016 C Ager, M Reilley, C Nicholas, T Bartkowiak, A Jaiswal, M Curran, ... Journal for ImmunoTherapy of Cancer 4, 107-221, 2016 | 12 | 2016 |
| Immunotherapeutic molecules and uses M Cobbold, D Millar US Patent 10,106,621, 2018 | 8 | 2018 |
| Antibody-peptide epitope conjugates for personalized cancer therapy S Zhang, C Yan, DG Millar, Q Yang, JM Heather, A Langenbucher, ... Cancer Research 82 (5), 773-784, 2022 | 6 | 2022 |
| Redirecting T-cells against AML in a multidimensional targeting space using T-cell engaging antibody circuits (TEAC) E Minogue, D Millar, Y Chuan, S Zhang, K Grauwet, M Guo, ... Blood 134, 2653, 2019 | 6 | 2019 |
| Immunotherapy M Cobbold, D Millar US Patent App. 14/986,046, 2016 | 4 | 2016 |
| Re-directed immunotherapy M Cobbold, D Millar US Patent 9,358,282, 2016 | 3 | 2016 |
| Agents and Methods M Cobbold, D Millar US Patent App. 14/428,449, 2015 | 2 | 2015 |
| Redirection of CMV-specific CD8 T-cell immunity in chronic lymphocytic leukaemia by manipulating the antigen expression profile LT Morton, DG Millar, M Carvalho-Gaspar, P Mistry, M Cobbold IMMUNOLOGY 143, 146-146, 2014 | 2 | 2014 |
| Antibody tumor-targeting assembly complexes M Cobbold, D Millar US Patent App. 17/257,391, 2021 | 1 | 2021 |
| Aberrant X chromosome skewing and acquired clonal hematopoiesis in adult-onset common variable immunodeficiency GK Wong, S Barmettler, JM Heather, D Millar, SA Penny, A Huissoon, ... JCI insight 4 (14), 2019 | 1 | 2019 |
| Re-directed immunotherapy M Cobbold, D Millar US Patent 10,287,321, 2019 | 1 | 2019 |
| Engineered release and presentation of antibody-bound viral antigens: A highly specific and novel immunotherapeutic approach to target cancer in vivo DG Millar, L Morton, MC Gaspar, P Mistry, HDL Peña, R Joseph, S Penny, ... Cancer Research 74 (19_Supplement), 2893-2893, 2014 | 1 | 2014 |
